What is the treatment for ringworm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ringworm (Tinea Infections)

For ringworm of the body (tinea corporis) and groin (tinea cruris), topical antifungal therapy with clotrimazole 1% or miconazole 2% cream applied twice daily for 2-4 weeks is first-line treatment, while scalp ringworm (tinea capitis) and nail infections (tinea unguium) require oral griseofulvin or terbinafine. 1, 2

Treatment by Body Site

Tinea Corporis (Body) and Tinea Cruris (Groin)

Topical therapy is the standard approach:

  • Clotrimazole 1% cream applied twice daily for 2-4 weeks is highly effective for localized infections 1, 3
  • Miconazole 2% cream applied twice daily for 2-4 weeks provides equivalent efficacy 1
  • Terbinafine cream demonstrates superior efficacy compared to placebo (RR 4.51, NNT 3) and may require shorter treatment duration (1-2 weeks) 3, 4
  • Naftifine 1% shows strong mycological cure rates (RR 2.38, NNT 3) 3

When to escalate to oral therapy:

  • Extensive disease covering large body surface areas 5
  • Failure to respond after 2 weeks of appropriate topical treatment 1
  • Immunocompromised patients 5
  • Hair follicle involvement 5

For extensive or resistant cases requiring oral therapy:

  • Oral fluconazole 150-200 mg weekly for 2-4 weeks 1
  • Continue treatment for at least one week after clinical clearing 4

Tinea Capitis (Scalp)

Oral systemic therapy is mandatory—topical agents alone are ineffective:

  • Griseofulvin is FDA-approved and remains first-line: 2

    • Adults: 500 mg daily (can give as 125 mg four times daily or 250 mg twice daily) 2
    • Children >2 years: 10 mg/kg daily (children 30-50 lbs: 125-250 mg daily; >50 lbs: 250-500 mg daily) 2
    • Duration: 4-6 weeks minimum 2
  • Oral terbinafine is considered first-line by many experts due to better tolerability, efficacy, and lower cost, though used off-label in children 5, 6

    • Duration: 6 weeks 7
  • Alternative agents (off-label): itraconazole and fluconazole offer shorter treatment intervals with acceptable safety profiles 6, 7

Critical point: Medication must be continued until the organism is completely eradicated as confirmed by clinical or laboratory examination—premature discontinuation leads to relapse 2

Tinea Pedis (Feet)

  • Topical azoles for 4 weeks (longer than body/groin infections) 4
  • Allylamine medications for 1-2 weeks (shorter duration due to superior efficacy) 4
  • Concomitant topical therapy is usually required as yeasts and bacteria may co-exist with dermatophytes 2

Tinea Unguium (Nails/Onychomycosis)

Oral therapy is required:

  • Oral terbinafine is first-line due to efficacy, tolerability, and cost 5
  • Griseofulvin alternative dosing: 2
    • Fingernails: minimum 4 months
    • Toenails: minimum 6 months (depends on rate of nail growth)

Key Clinical Considerations

Diagnosis confirmation is essential before treatment:

  • Direct microscopic examination with KOH preparation 2
  • Fungal culture on appropriate medium 2
  • Nail biopsy for onychomycosis 2

Common pitfall: Clinical diagnosis without laboratory confirmation is unreliable—tinea corporis mimics eczema, and onychomycosis resembles dystrophic nails from trauma or psoriasis 5

Hygiene measures must accompany pharmacotherapy:

  • Control sources of infection and reinfection 2
  • Address exacerbating factors, particularly skin moisture 4

Monitoring for treatment failure:

  • If no improvement after 2 weeks of appropriate therapy, switch to a different antifungal class 1
  • Emerging resistant tinea infections may require prolonged oral therapy and specialized diagnostic testing 5

Avoid combination antifungal-corticosteroid products as part of antifungal stewardship to prevent resistance, despite some evidence showing higher short-term clinical cure rates 5, 3

Griseofulvin is NOT effective for: bacterial infections, candidiasis, histoplasmosis, or other non-dermatophyte fungal infections 2

References

Guideline

Treatment of Ringworm Under the Axilla

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Diagnosis and Management of Tinea Infections.

American family physician, 2025

Research

Pediatric tinea capitis: recognition and management.

American journal of clinical dermatology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.